5/19/2022China Approves Bayer/MSD's Verquvo (vericiguat) for Chronic Heart Fail...

5/19/2022CTTQ and Symphogen Enter Pact for Global Rights of Latter's mAb Sym022

5/19/2022CDE Issues the List of Reference Formulations for GQCE Studies (54th B...

5/19/2022WHO Validates 3rd Chinese COVID-19 Vaccine for Emergency Use

5/19/2022APAC Hospital Priorities 2022: Strategic Implications for Pharma Compa...

5/19/2022As Losses Narrow, Is Zai Lab Finally Finding its Winning Formula?

5/19/2022Pediatric Drug Development A New Investment Area in China (PharmaDJ's ...

5/18/2022'Startup Like No Other': China's Hengrui launches Luzsana with Big Pha...

5/17/2022Upcoming Event: 6th International Conference on Emerging Infectious Di...

5/17/2022SMEI: Chinese Public Medical Institution Drug Sales Surged 7.2% in 202...

5/17/2022CDE Issues the Guidelines for Evaluation of Immune-Related Adverse Eve...

5/17/2022NHSA Completes Building of Unified National BMI Information Platform

5/17/2022433 Listed Chinese Pharma Companies Report Their Annual Performance in...

5/16/2022Visus and Zhaoke Enter Exclusive Licensing Deal for Brimochol PF and C...

5/16/2022Kelun Out-licenses Anticancer Drug Candidate to MSD in $1.4B Deal

5/16/2022Bayer's Q1/2022 Business Undercut by Xarelto Generics in China

5/16/2022Kintor Pharma Included in MSCI China Index

5/16/2022Pfizer Leads April Approvals in China with Two JAK Inhibitors (PharmaD...

5/16/2022Judgement on the First Drug Patent Linkage Lawsuit in China Is Issued

5/13/2022Green Valley Aborts Trial of Its Alzheimer's Drug amid Fundraisng and ...

5/13/2022Drug R&D and Product Registration News Digest May 2022 (2)

5/13/2022Review of Leading Listed Chinese Pharma Cos by R&D Spending in 2021

5/13/2022SMEI: Top 20 Pharma Cos by Hospital Drug Sales in 2021

5/12/2022Henlius and Eurofarma Entered into a License Deal for Three Henlius P...

5/12/2022Merck KGaA Warns of Volatile 2022 Thanks to War in Ukraine and Fresh C...

5/12/2022China Resources in Talks to Take Sihuan Pharma Private At $3B Valuatio...

5/12/2022Chinese Securities Regulators Lay Out Audit Pathway for U.S. Listings ...

5/12/2022Ready for FDA, Can Hengrui's China-made PD-1 Liver Cancer Immunotherap...

5/11/2022BeiGene, Hutchmed, Zai Lab Tagged for Potential US Delisting Under SEC...

5/11/2022China to Help More Biotech Firms Get Listed Domestically to Boost Sect...

Page:84/719 Total number of articles:21546: [First][<<] [82] [83] [84] [85] [86] [>>] [End]